PEAK6 Strategic Capital
Austin, Texas, United StatesFounded 1997
PEAK6 Strategic Capital is the investment arm of PEAK6, investing in AI and transformational technologies across private equity, venture, and public markets. It partners with founders providing capital, operational expertise, and strategic support across sectors including AI, fintech, biotech, climate tech, and consumer goods.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Average disclosed round size is $81.5M (across 19 rounds with reported amounts).
Portfolio
15
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
JP
Jake Poliner
Investment Professional
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
21 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Apptronik | Growth | — | Feb 2026 |
 dub | Series A | $30M | May 2025 |
 Cala Health | Series C | $50M | Mar 2025 |
| Cala Health | Growth | $50M | Dec 2024 |
| dub | Seed | $17M | Feb 2024 |
 Vedanta Biosciences | Series D | $40M | Jan 2024 |
| dub | Series A | $30M | Jan 2024 |
 Tradier | Series B | — | Apr 2023 |
 ImmunOs Therapeutics | Series B | $74M | Jun 2022 |
 ImmunOs | Series B | $74M | Jun 2022 |
| LLEX Markets | Series A | $15M | Feb 2022 |
| LLEX Markets | Series A | $15M | Jan 2022 |
 Lex | Series A | $15M | Jan 2022 |
 Mekonos | Series A | $25M | Nov 2021 |
 Thrasio | Series D | $1B | Oct 2021 |
| Cala Health | Series C | $50M | Jan 2021 |
 Sportsdigita | Series A | $10M | Nov 2020 |
 Bambu | Series B | $10M | Jul 2019 |
 Lex | Series A | $15M | — |
| Sportsdigita | Seed | $3M | — |
 Eclypsium, Inc | Series C | $25M | — |
Top Co-Investors
GV4 shared
Gaingels4 shared
MUFG Innovation Partners4 shared
Two Lanterns Venture Capital4 shared
Khosla Ventures4 shared
Action Potential Venture Capital3 shared
Ascension Ventures3 shared
Triventures3 shared
Lightstone Ventures3 shared
Lux Capital3 shared
Silicon Valley Bank3 shared
Neo3 shared
Notable Capital3 shared
Correlation Ventures3 shared
Pfizer Ventures3 shared
Greycroft3 shared
Alumni Ventures3 shared
Imaginary Ventures2 shared
BioMed Ventures2 shared
Last updated: 20 October 2026